We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




First Humans Tested with New MRI Technology

By HospiMedica International staff writers
Posted on 19 Jun 2017
A new metamaterial-enhanced MRI technique has been tested for the first time on humans.

The technique enhances the local sensitivity of Magnetic Resonance Imaging (MRI) scanners and could be used to acquire higher-resolution MRI images, reduce image acquisition time, improve patient comfort, and improve the diagnosis of disease.

The new technology was designed and tested by scientists from the Leiden University Medical Center (Leiden, the Netherlands) and ITMO University in (Saint Petersburg, Russia), and was published in the May 2017 issue of the journal Scientific Reports.

Current MRI technology suffers from an intrinsically lower signal-to-noise ratio, and longer acquisition time than Computed Tomography (CT), or ultrasound. More...
However, the new MRI technique enhances local sensitivity and enhances the signal-to-noise ratio. The technique uses a thin metasurface of conducting copper strips attached to a thin flexible substrate, and integrated this into close-fitting receive coil arrays inside an MRI scanner.

Rita Schmidt, researcher at the Department of Radiology, Leiden University Medical Center, and first author of the study, said, "We placed such a metasurface under the patient's head, after that, the local sensitivity increased by 50 percent. This allowed us to obtain higher image and spectroscopic signals from the occipital cortex. Such devices could potentially reduce the duration of MRI studies and improve its comfort for subjects. Our technology can be applied for producing metamaterial-inspired, ultra-thin devices for many different types of MRI scans, but in each case, one should first carry out a series of computer simulations, as we have done in this work. One needs to make sure that the metasurface is appropriately coupled."

Related Links:
Leiden University Medical Center
ITMO University

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology System
Riviera SPV AT
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.